Active ingredientPrulifloxacinCat. No. P-P230-001CAS 123447-62-1Family · Pharmaceutical analytical standards
Prulifloxacin
A fluoroquinolone antibiotic patented in Japan in 1987 and approved there in 1997; it is a prodrug that the body converts into the active compound ulifloxacin, and it is used mainly for urinary infections and flare-ups of chronic bronchitis. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Its skeleton contains a rare four-membered ring with sulfur and nitrogen (thiazete), fused to the quinolone core; besides Japan it has also been approved in Italy, China, India and Greece.
Go to the active ingredient →Active ingredientPrulifloxacinCat. No. P-P230-001CAS 123447-62-1
Isotopically labelledPrulifloxacin-d8Cat. No. P-P230-002CAS 1246819-37-3
ImpurityPrulifloxacin Impurity 1Cat. No. P-P230-003CAS 156834-58-1
ImpurityPrulifloxacin Impurity 2Cat. No. P-P230-004CAS 173599-92-3
ImpurityPrulifloxacin Impurity 3Cat. No. P-P230-005CAS 187741-43-1
ImpurityPrulifloxacin Impurity 4Cat. No. P-P230-006CAS 156834-57-0
ImpurityPrulifloxacin Impurity 5Cat. No. P-P230-007No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.